0000899243-22-012855.txt : 20220330
0000899243-22-012855.hdr.sgml : 20220330
20220330203154
ACCESSION NUMBER: 0000899243-22-012855
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220330
FILED AS OF DATE: 20220330
DATE AS OF CHANGE: 20220330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Annis Allen
CENTRAL INDEX KEY: 0001709601
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 22788672
MAIL ADDRESS:
STREET 1: C/O AILERON THERAPEUTICS, INC.
STREET 2: 281 ALBANY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-03-30
2022-03-24
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001709601
Annis Allen
C/O AILERON THERAPEUTICS, INC.
285 SUMMER STREET, SUITE 101
BOSTON
MA
02210
0
1
0
0
SVP, Research
Stock Option (right to buy)
0.48
2022-03-30
4
A
0
313000
0.00
A
2032-03-29
Common Stock
313000
313000
D
This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022.
The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026.
/s/ Richard Wanstall, attorney in fact for David Allen Annis
2022-03-30